Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.52 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.52 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.52 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.52 |
| ▸ | HTR1D | P28221 | 1/20 | 0.52 |
| ▸ | HTR1B | P28222 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | BCHE | P06276 | 4/20 | 0.48 |
| ▸ | ACHE | P22303 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3452699 | 0.90 | CALM1 (0.57) | TSHRADRA2AADRA2BADRA2CADRA1D | |
| SCHEMBL6547963 | 0.90 | TSHR (0.71) | TSHRADRA2AADRA2BADRA2CADRA1D | |
| SCHEMBL6284119 | 0.88 | SMN1; SMN2 (0.49) | TSHRADRA2AADRA2BADRA2CADRA1D | |
| SCHEMBL19936605 | 0.88 | ESR1 (0.52) | TSHRADRA2AADRA2BADRA2CADRA1D | |
| SCHEMBL9440498 | 0.88 | APP (0.61) | TSHRADRA2AADRA2BADRA2CADRA1D | |
| SCHEMBL23009776 | 0.88 | ADRA2A (0.44) | TSHRADRA2AADRA2BADRA2CADRA1D | |
| SCHEMBL12733320 | 0.88 | LMNA (0.73) | TSHRLMNATYRALDH1A1 | |
| SCHEMBL270340 | 0.86 | ALDH1A1 (0.62) | TSHRADRA2AADRA2BADRA2CADRA1D | |
| SCHEMBL19599172 | 0.86 | SLC22A2 (0.45) | TSHRADRA2AADRA2BADRA2CADRA1D | |
| SCHEMBL24515353 | 0.84 | TSHR (0.43) | TSHRADRA2AADRA2BADRA2CADRA1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6503662-B1 | Tert-butylbenzene derivative prevents oxidation and decomposition of solvent at the time of charging which causes decreased battery characteristics | UBE INDUSTRIES, LTD. (JP) | 2003-01-07 | — | — | US | claimed |
| US-12398089-B2 | Method for preparing organic carboxylic ester by using combined catalyst of aryl bidentate phosphine ligand | NANJING CHENGZHI CLEAN ENERGY CO. LTD. (CN) | 2025-08-26 | — | — | US | disclosed |
| US-11723990-B2 | Library of pH responsive polymers and nanoprobes thereof | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-08-15 | — | — | US | disclosed |
| EP-4062894-A1 | DENTAL PHOTOCURABLE COMPOSITION HAVING EXCELLENT STORAGE STABILITY | Shofu Inc. (JP) | 2022-09-28 | — | — | EP | disclosed |
| US-20220298097-A1 | METHOD FOR PREPARING ORGANIC CARBOXYLIC ESTER BY USING COMBINED CATALYST OF ARYL BIDENTATE PHOSPHINE LIGAND | NANJING CHENGZHI CLEAN ENERGY CO. LTD. (CN) | 2022-09-22 | — | — | US | disclosed |
| US-20220287919-A1 | PHOTOCURABLE COMPOSITION EXCELLENT IN CURING DEPTH | SHOFU INC. (JP) | 2022-09-15 | — | — | US | disclosed |
| WO-2021129138-A1 | METHOD FOR PREPARING ORGANIC CARBOXYLIC ESTER BY MEANS OF COMBINATORIAL CATALYSIS WITH ARYL BIDENTATE PHOSPHINE LIGAND | 南京诚志清洁能源有限公司 | 2021-07-01 | — | — | WO | disclosed |
| WO-2020243381-A1 | FAST PHOTOCURABLE POLYCYCLOOLEFIN COMPOSITIONS AS OPTICAL OR 3D PRINTING MATERIALS | PROMERUS, LLC (US) | 2020-12-03 | — | — | WO | disclosed |
| CN-111087306-A | Method for preparing organic carboxylic ester by aryl bidentate phosphine ligand combined catalysis | 南京诚志清洁能源有限公司 | 2020-05-01 | — | — | CN | disclosed |
| US-9869929-B2 | Resin, resist composition and method for producing resist pattern | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-01-16 | — | — | US | disclosed |
| US-6358665-B1 | ONIUM SALT PRECURSOR FOR GENERATING FLUOROALKYLSULFONATE | CLARIANT INTERNATIONAL LTD. (CH) | 2002-03-19 | — | — | US | disclosed |
| EP-1138687-A1 | METALLOCENE COMPOUND, PROCESS FOR PRODUCING METALLOCENE COMPOUND, OLEFIN POLYMERIZATION CATALYST, PROCESS FOR PRODUCING POLYOLEFIN, AND POLYOLEFIN | Mitsui Chemicals, Inc. (JP) | 2001-10-04 | — | — | EP | disclosed |
| EP-1033624-A1 | RADIATION-SENSITIVE COMPOSITION OF CHEMICAL AMPLIFICATION TYPE | Clariant International Ltd. (CH) | 2000-09-06 | — | — | EP | disclosed |
| EP-0693468-B1 | A method of making Diaryliodonium fluoroalkyl sulphonate salts | MINNESOTA MINING & MFG (US) | 1999-06-09 | — | — | EP | disclosed |
| US-5710320-A | Diaryliodonium fluoroalkyl sulfonate salts and a method of making | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-01-20 | — | — | US | disclosed |
| US-5488147-A | Diaryliodonium fluoroalkyl sulfonate salts and a method of making | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-01-30 | — | — | US | disclosed |
| EP-0693468-A2 | Diaryliodonium fluoroalkyl sulphonate salts and a method of making them | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-01-24 | — | — | EP | disclosed |
| US-4814483-A | IRON CHLORIDE CATALYZED REACTION | BAYER AKTIENGESELLSCHAFT (DE) | 1989-03-21 | — | — | US | disclosed |
| EP-0226152-B1 | PROCESS FOR PREPARING OPTIONALLY-SUBSTITUTED 2-BENZYL TOLUENES | BAYER AG (DE) | 1989-01-18 | — | — | EP | disclosed |
| EP-0226152-A1 | Process for preparing optionally-substituted 2-benzyl toluenes | BAYER AG (DE) | 1987-06-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220287919-A1 | PHOTOCURABLE COMPOSITION EXCELLENT IN CURING DEPTH | ODC1, AOC2, CCNT1 | TSHR 4012/4885ADRA2A 1573/4885ADRA2B 1406/4885 |
| US-20220298097-A1 | METHOD FOR PREPARING ORGANIC CARBOXYLIC ESTER BY USING COMBINED CATALYST OF ARYL BIDENTATE PHOSPHINE LIGAND | POF1B, ADH1C, OSBP | TSHR 2891/4885ADRA2A 3967/4885ADRA2B 3785/4885 |
| US-12398089-B2 | Method for preparing organic carboxylic ester by using combined catalyst of aryl bidentate phosphine ligand | POF1B, ADH1C, OSBP | TSHR 2891/4885ADRA2A 3967/4885ADRA2B 3785/4885 |
| US-11723990-B2 | Library of pH responsive polymers and nanoprobes thereof | MSN, CD44, CD47 | TSHR 4300/4885ADRA2A 4696/4885ADRA2B 4576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.